Análisis de las publicaciones del personal docente e investigador de las facultades españolas de Bellas Artes

8 p.

Celiac disease in the Mediterranean area

Background: The World Gastroenterology Organization recommends developing national guidelines for the diagnosis of Celiac Disease (CD): hence a profile of the diagnosis of CD in each country is required. We aim to describe a cross-sectional picture of the clinical features and diagnostic facilities in 16 countries of the Mediterranean basin. Since a new ESPGHAN diagnostic protocol was recently published, our secondary aim is to estimate how many cases in the same area could be identified without a small intestinal biopsy. Methods: By a stratified cross-sectional retrospective study design, we examined clinical, histological and laboratory data from 749 consecutive unselected CD children diagnosed by national referral centers. Results: The vast majority of cases were diagnosed before the age of 10 (median: 5 years), affected by diarrhea, weight loss and food refusal, as expected. Only 59 cases (7.8%) did not suffer of major complaints. Tissue transglutaminase (tTG) assay was available, but one-third of centers reported financial constraints in the regular purchase of the assay kits. 252 cases (33.6%) showed tTG values over 10 times the local normal limit. Endomysial antibodies and HLA typing were routinely available in only half of the centers. CD was mainly diagnosed from small intestinal biopsy, available in all centers. Based on these data, only 154/749 cases (20.5%) would have qualified for a diagnosis of CD without a small intestinal biopsy, according to the new ESPGHAN protocol. Conclusions: This cross-sectional study of CD in the Mediterranean referral centers offers a puzzling picture of the capacities to deal with the emerging epidemic of CD in the area, giving a substantive support to the World Gastroenterology Organization guidelines.

El fraude empresarial: perspectiva internacional

Este trabajo analiza el fraude empresarial desde una perspectiva internacional. En los últimos años, ha estado muy presente en casos como el de Enron, WorldCom, Royal Ahold o PARMALAT, en los que se ven afectados la propia empresa, los trabajadores, el gobierno y, especialmente, los inversores, con pérdidas que pueden alcanzar millones de dólares. El fraude también afecta a la imagen de las empresas y en la motivación de los trabajadores, y además a menudo es causa de denuncias y penas de prisión. En función del tamaño de la empresa y del sector, la frecuencia con la que se cometen los actos fraudulentos y las pérdidas causadas varían. Asimismo, estos fraudes afectan a todas las regiones del mundo, aunque de manera desigual. Pero es en aquellas regiones más desarrolladas donde se le presta más atención al tema, y donde se han tomado numerosas medidas para intentar impedir estos actos ilícitos. Algunas de las más importantes son las propuestas por las Naciones Unidas: El Pacto Mundial y la Convención contra la Corrupción. También cabe destacar la Oficina Europea de Lucha Contra el Fraude, a nivel europeo, o la Foreign Corrupt Practices Act y la Ley Sarbanes-Oxley, en Estados Unidos. A pesar de estas medidas, en los últimos años el nivel de fraude ha aumentado.

Celiac disease in the Mediterranean area

Background: The World Gastroenterology Organization recommends developing national guidelines for the diagnosis of Celiac Disease (CD): hence a profile of the diagnosis of CD in each country is required. We aim to describe a cross-sectional picture of the clinical features and diagnostic facilities in 16 countries of the Mediterranean basin. Since a new ESPGHAN diagnostic protocol was recently published, our secondary aim is to estimate how many cases in the same area could be identified without a small intestinal biopsy. Methods: By a stratified cross-sectional retrospective study design, we examined clinical, histological and laboratory data from 749 consecutive unselected CD children diagnosed by national referral centers. Results: The vast majority of cases were diagnosed before the age of 10 (median: 5 years), affected by diarrhea, weight loss and food refusal, as expected. Only 59 cases (7.8%) did not suffer of major complaints. Tissue transglutaminase (tTG) assay was available, but one-third of centers reported financial constraints in the regular purchase of the assay kits. 252 cases (33.6%) showed tTG values over 10 times the local normal limit. Endomysial antibodies and HLA typing were routinely available in only half of the centers. CD was mainly diagnosed from small intestinal biopsy, available in all centers. Based on these data, only 154/749 cases (20.5%) would have qualified for a diagnosis of CD without a small intestinal biopsy, according to the new ESPGHAN protocol. Conclusions: This cross-sectional study of CD in the Mediterranean referral centers offers a puzzling picture of the capacities to deal with the emerging epidemic of CD in the area, giving a substantive support to the World Gastroenterology Organization guidelines.